For example, mir-10b, which is up-regulated in metastatic breast carcinomas compared with the benign breast lesions, targets E-cadherin to promote tumor cell invasion, while mir-122 is down-regulated in breast cancer cells and functions to inhibit tumorigenesis of the cancer by targeting IGF1R66, 67. The gene discussed is CDH1; the disease is breast carcinoma.